Company: CORT
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048841
Chunk: 0

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
ITEM 1.  FINANCIAL STATEMENTS

CORCEPT THERAPEUTICS INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)September 30,2025December 31,2024 (Unaudited)(See Note 1)ASSETS  Current assets:  Cash and cash equivalents$125,138 $127,665 Short-term marketable securities296,545 255,669 Trade receivables, net of allowances69,629 53,976 Inventory12,349 12,412 Prepaid expenses and other current assets37,469 21,880 Total current assets541,130 471,602 Strategic inventory12,002 3,583 Operating lease right-of-use asset4,776 5,324 Property and equipment, net2,094 2,689 Long-term marketable securities102,557 219,831 Other assets8,049 6,610 Deferred tax assets, net152,999 130,914 Total assets$823,607 $840,553 LIABILITIES AND STOCKHOLDERS’ EQUITYCurrent liabilities:Accounts payable$34,446 $15,376 Accrued research and development expenses28,322 33,868 Accrued and other liabilities108,447 90,700 Short-term operating lease liability1,050 829 Total current liabilities172,265 140,773 Long-term operating lease liability5,308 6,107 Long-term accrued income taxes payable14,132 14,084 Total liabilities191,705 160,964 Commitments and contingencies (Note 4)Stockholders’ equity:Preferred stock— — Common stock139 136 Treasury stock(923,290)(696,173)Additional paid-in capital933,613 832,108 Accumulated other comprehensive income (loss)2,341 (217)Retained earnings619,099 543,735 Total stockholders’ equity631,902 679,589 Total liabilities and stockholders’ equity$823,607 $840,553 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

CORCEPT THERAPEUTICS INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In thousands, except per share data)Three Months Ended